Comments

Cogent Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Cogent Biosciences (COGT) operate in?

Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

COGTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$6.61

0.142.16%

At close: -

$6.61

0.000.00%

After Hours: 4:24 PM EDT

Cogent Biosciences (COGT) Forecast

News Earnings Cogent Biosciences (COGT) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Cogent Biosciences Stock Price, Quotes and Forecasts | NASDAQ:COGT | Benzinga

Explore Cogent Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for COGT.

Open	$6.52
Close	$6.61
Volume / Avg.	923.63K / 1.34M
Day Range	$6.46 - $6.78
52 Wk Range	5.79 - 12.61
Market Cap	$752.55M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	11.47%
Days to Cover	11.5

Recent News

Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Is Cogent Biosciences Stock Trading Higher On Monday?

Cogent Biosciences' SUMMIT trial shows bezuclastinib improves symptoms and quality of life in systemic mastocytosis, with favorable safety data.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.52
Close	$6.61
Volume / Avg.	923.63K / 1.34M
Day Range	$6.46 - $6.78
52 Wk Range	5.79 - 12.61
Market Cap	$752.55M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	11.47%
Days to Cover	11.5

About Cogent Biosciences Inc

Sector

Health Care

Industry

Biotechnology

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetic...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cogent Biosciences (COGT) stock?

You can purchase shares of Cogent Biosciences (NASDAQ:COGT) through any online brokerage.

View our list of the best stock brokerages

Who are Cogent Biosciences (COGT) competitors?

Other companies in Cogent Biosciences’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Gyre Therapeutics (NASDAQ:GYRE), Valneva (NASDAQ:VALN) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for Cogent Biosciences (COGT) stock?

Cogent Biosciences has a consensus price target of $16.80.

What is the current price for Cogent Biosciences (COGT)?

The stock price for Cogent Biosciences (NASDAQ: COGT) is $6.61 last updated March 27, 2025 at 4:24 PM EDT.

Does Cogent Biosciences (COGT) pay a dividend?

There are no upcoming dividends for Cogent Biosciences.

When is Cogent Biosciences (NASDAQ:COGT) reporting earnings?

Cogent Biosciences’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is Cogent Biosciences (COGT) going to split?

There is no upcoming split for Cogent Biosciences.

What sector and industry does Cogent Biosciences (COGT) operate in?

Cogent Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.